{"id":"tp-56746","type":"article-newspaper","title":"Rezolute Reports 13 of 16 Patients Achieved at Least 50% Glucose Infusion Rate Reduction","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/56746","datePublished":"2026-11-13T14:10:47.000Z","dateModified":"2026-11-13T14:10:47.000Z","language":"en","abstract":"The Phase 3 upLIFT study is evaluating ersodetug for tumor hyperinsulinism.","section":"Business","references":[]}